{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:34:22Z","timestamp":1786494862362,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ygyno.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T03:21:18Z","timestamp":1479352878000},"page":"558-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6 months after uterine evacuation?"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-6182","authenticated-orcid":false,"given":"Antonio","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Burl\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izildinha","family":"Maest\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Yazaki","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mauro","family":"Madi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elza","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross S","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2016.09.012_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2016.09.012_bb0010","doi-asserted-by":"crossref","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"ESMO guidelines working group. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Seckl","year":"2013","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.09.012_bb0015","first-page":"3","article-title":"Diagnosis, classification and treatment of gestational trophoblastic neoplasia","volume":"128","author":"Biscaro","year":"2013","journal-title":"Rev. Bras. Ginecol. Obstet."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2016.09.012_bb0020","first-page":"241","article-title":"Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers. Results after 12years since International FIGO 2000 consensus","volume":"59","author":"Braga","year":"2014","journal-title":"J Reprod Med"},{"issue":"1","key":"10.1016\/j.ygyno.2016.09.012_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.11.014","article-title":"Trends in incidence for gestational trophoblastic disease over the last 20years in a population-based study","volume":"140","author":"Eysbouts","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.09.012_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2012.07.116","article-title":"Current advances in the management of gestational trophoblastic disease","volume":"128","author":"Berkowitz","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.09.012_bb0035","first-page":"143","article-title":"Challenges of the treatment of patients with gestational trophoblastic disease","volume":"34","author":"Maesta","year":"2012","journal-title":"Rev. Bras. Ginecol. Obstet."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2016.09.012_bb0040","first-page":"224","article-title":"Centralized coordination of decentralized assistance for patients with gestational trophoblastic disease in Brazil. A viable strategy for developing countries","volume":"61","author":"Braga","year":"2016","journal-title":"J. Reprod. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2016.09.012_bb0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000","volume":"77","author":"F\u00e9d\u00e9ration Internationale de Gyn\u00e9cologie et d'Obst\u00e9trique Oncology Committee","year":"2002","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"9811","key":"10.1016\/j.ygyno.2016.09.012_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(11)61265-8","article-title":"Chemotherapy and human chorionic gonadotropin concentrations 6months after uterine evacuation of molar pregnancy: a retrospective cohort study","volume":"379","author":"Agarwal","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ygyno.2016.09.012_bb0055","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1054\/bjoc.1999.1124","article-title":"Treatment of persistent trophoblastic disease later than 6months after diagnosis of molar pregnancy","volume":"82","author":"Gillespie","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2016.09.012_bb0060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mob.2003.271","article-title":"Persistent low levels of human chorionic gonadotropin: a premalignant gestational trophoblastic disease","volume":"188","author":"Khanlian","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.09.012_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2005.12.048","article-title":"Gestational trophoblastic disease: 4. Presentation with persistent low positive human chorionic gonadotropin test results","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.012_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/jog.12953","article-title":"Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotropin","author":"Qian","year":"2016","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2016.09.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.13867","article-title":"Late spontaneous resolution of persistent molar pregnancy","author":"Taylor","year":"2016","journal-title":"BJOG"},{"issue":"13","key":"10.1016\/j.ygyno.2016.09.012_bb0080","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ejca.2015.05.026","article-title":"Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases","volume":"51","author":"Bolze","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2016.09.012_bb0085","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/S0020-7292(12)60026-5","article-title":"FIGO Cancer Report 2012. Trophoblastic disease","volume":"119","author":"Ngan","year":"2012","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2016.09.012_bb0090","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijgo.2015.06.008","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"131","author":"Ngan","year":"2015","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2016.09.012_bb0095","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E","article-title":"Risk and prognostic factors in trophoblastic neoplasia","volume":"38","author":"Bagshawe","year":"1976","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2016.09.012_bb0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bjc.6603416","article-title":"The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours","volume":"95","author":"Powles","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"9683","key":"10.1016\/j.ygyno.2016.09.012_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(09)60618-8","article-title":"Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study","volume":"374","author":"Schmid","year":"2009","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.09.012_bb0110","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0020-7292(98)80010-6","article-title":"Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT - 25years experiences of KRI-TRD","volume":"60","author":"Kim","year":"1998","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816314135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816314135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:37:34Z","timestamp":1620826654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816314135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0090825816314135"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.09.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}